Levodopa alone compared with levodopa-sparing therapy as initial treatment for Parkinson’s disease: a meta-analysis

Evaluation of the Efficacy of Pramipexole for Treating Levodopa-induced Dyskinesia in Patients with Parkinson's Disease

(2014) Hiroya Utsumi et al.   INTERNAL MEDICINE

Pharmacological Treatment of Parkinson Disease

(2014) Barbara S. Connolly et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial

(2014) PD MED Collaborative Group   LANCET

Initiating dopaminergic treatment in Parkinson's disease

(2014) Anthony E Lang et al.   LANCET

Measuring Disease Progression in Early Parkinson Disease

(2014) Sotirios A. Parashos et al.   JAMA Neurology

Therapeutic prospects for Parkinson disease

(2013) C. Warren Olanow et al.   ANNALS OF NEUROLOGY

Meta-analysis of data from animal studies: A practical guide

(2013) H.M. Vesterinen et al.   JOURNAL OF NEUROSCIENCE METHODS

Effects of dopaminergic treatment on striatal dopamine turnover in de novo Parkinson disease

(2013) A. Storch et al.   NEUROLOGY

Caregiver strain in Parkinson's disease: National Parkinson Foundation Quality Initiative Study

(2013) O. Oguh et al.   PARKINSONISM & RELATED DISORDERS

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease

(2012) J. J. Ferreira et al.   EUROPEAN JOURNAL OF NEUROLOGY

Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease

(2009)   ARCHIVES OF NEUROLOGY

Mechanisms compensating for dopamine loss in early Parkinson disease

(2009) J. Brotchie et al.   NEUROLOGY

Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD

(2008) R. Katzenschlager et al.   NEUROLOGY